Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Shin DS, Park K, Garon E, Dubinett S, et al. Semin Oncol 2022 Jul 2. pii: S0093-7754(22)00045.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shin DS, Park K, Garon E, Dubinett S, et al. Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Semin Oncol 2022 Jul 2. pii: S0093-7754(22)00045.
PMID: 35851153